XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating Activities    
Net income $ 80,810 $ 108,431
Depreciation and amortization 36,270 29,284
Stock-based compensation (Note 11) 13,562 3,042
Pension expense (Note 15) 2,079 6,647
Deferred income tax benefit (Note 10) (6,665) (1,312)
Loss on asset dispositions, net 423 189
Pension contributions (Note 15) (5,768) (5,672)
Currency exchange (gains) losses, net (359) 3,821
Product liability expense (Note 18) 25,235 4,878
Collections on insurance receivables and notes receivable, insurance companies (Note 18) 15,437 10,844
Product liability payments (Note 18) (32,499) (6,648)
Changes in:    
Trade receivables 40,167 23,744
Inventories (Note 3) (32,765) (70,148)
Accounts payable (855) (8,956)
Other current assets and liabilities (2,410) 12,065
Other noncurrent assets and liabilities (2,519) (54)
Cash Flow From Operating Activities 130,143 110,155
Investing Activities    
Capital expenditures (30,963) (32,698)
Acquisition, net of cash acquired (Note 19) (392,437) 0
Purchase of short-term investments (Note 17) (108,938) (174,337)
Proceeds from maturities of short-term investments (Note 17) 135,000 155,000
Property disposals and other investing (5,249) 334
Cash Flow Used in Investing Activities (402,587) (51,701)
Financing Activities    
Proceeds from long-term debt (Note 12) 1,341,734 779,000
Payments on long-term debt (Note 12) (1,032,875) (784,000)
Debt issuance costs (2,080) 0
Cash dividends paid (51,322) (49,811)
Acquisition of noncontrolling interest in consolidated subsidiaries (Note 19) (13,381) 0
Distributions to noncontrolling interests (Note 19) (5,632) 0
Company stock purchases (Note 7) (6,137) (28,691)
Exercise of stock options (Note 7) 2,671 6,969
Employee stock purchase plan (Note 7) 452 390
Cash Flow From (Used in) Financing Activities 233,430 (76,143)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (4,177) (1,668)
Decrease in cash, cash equivalents and restricted cash (43,191) (19,357)
Beginning cash, cash equivalents and restricted cash 161,034 152,543
Ending cash, cash equivalents and restricted cash 117,843 133,186
Supplemental cash flow information:    
Cash and cash equivalents (Note 2) 117,302 132,830
Restricted cash included in prepaid expenses and other current assets 541 356
Total cash, cash equivalents and restricted cash $ 117,843 $ 133,186